ZyVersa Therapeutics Correlations
| ZVSA Stock | 0.74 0.01 0.67% |
The correlation of ZyVersa Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ZyVersa Therapeutics Correlation With Market
Significant diversification
The correlation between ZyVersa Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
ZyVersa |
Moving together with ZyVersa Stock
| 0.71 | CMND | Clearmind Medicine Common | PairCorr |
| 0.64 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
| 0.71 | CAT | Caterpillar | PairCorr |
| 0.82 | HD | Home Depot | PairCorr |
| 0.67 | DIS | Walt Disney | PairCorr |
Moving against ZyVersa Stock
| 0.52 | LUCD | Lucid Diagnostics | PairCorr |
| 0.51 | PG | Procter Gamble | PairCorr |
| 0.37 | WM | Waste Management | PairCorr |
| 0.59 | JNJ | Johnson Johnson | PairCorr |
| 0.57 | T | ATT Inc Earnings Call Today | PairCorr |
| 0.4 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
| 0.39 | INTC | Intel | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ZyVersa Stock performing well and ZyVersa Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ZyVersa Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CNSP | 5.71 | (0.05) | 0.00 | (0.19) | 0.00 | 12.10 | 70.89 | |||
| EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VECT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AVRO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IMMX | 3.38 | (0.09) | 0.00 | (8.37) | 0.00 | 6.82 | 26.42 | |||
| HEPA | 9.87 | (3.91) | 0.00 | (5.38) | 0.00 | 16.37 | 90.05 | |||
| VIRI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ZURA | 4.61 | (0.40) | 0.00 | (0.23) | 0.00 | 9.79 | 29.06 | |||
| NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ZyVersa Therapeutics Corporate Management
| LaBella MS | Chief RD | Profile | |
| Melda Oconnell | Senior Development | Profile | |
| Pablo MD | Chief Board | Profile | |
| MD FACC | Senior Officer | Profile | |
| Karen Cashmere | Chief Officer | Profile |